Lincoln Pharmaceuticals makes additional investment in subsidiary

Explore Business Standard
Associate Sponsors
Co-sponsor

Acquires additional 36.58% stake in Lincoln Parenteral
Lincoln Pharmaceuticals announced that it has acquired 36.58% additional equity in its subsidiary, Lincoln Parenteral, taking the total investment up to 98.58%.Powered by Capital Market - Live News
First Published: Jul 30 2015 | 9:14 AM IST